>> Monday
>> Tuesday
>> Wednesday
Wednesday 02 July 2025
08:30 - 09:30
Session 71: Embryos or embryoids? On the moral status and use of embryo-like-entities in research
Wednesday 02 July 2025
08:30 - 09:30: Session 71: Embryos or embryoids? On the moral status and use of embryo-like-entities in research:
Chairperson to be announced
08:30 - 08:50
The closer the knit, the tighter the fit: conceptual and ethical issues of human embryo modelling
Ana Pereira Daoud, The Netherlands
09:00 - 09:20
What is an embryo? A new definition in an ethical framework
08:30 - 09:30
Session 72: Guidelines session:ESHRE ovarian stimulation guideline: interactive session
08:30 - 09:30: Session 72: Guidelines session:ESHRE ovarian stimulation guideline: interactive session:
Nikolaos P. Polyzos, Spain
Chairperson to be announced
08:30 - 08:50
Highlights of the updated ovarian stimulation guideline
Frank J. Broekmans, The Netherlands
09:00 - 09:30
Recommendations on ovarian stimulation : time to vote -Interactive discussion
Nikolaos P. Polyzos, Spain
08:30 - 09:30
Session 73: Debate: how to monitor ovarian stimulation
08:30 - 09:30: Session 73: Debate: how to monitor ovarian stimulation:
Dinka Pavicic Baldani, Croatia
Chairperson to be announced
08:30 - 08:45
Monitor all parameters
08:45 - 09:00
Monitor only relevant parameters
08:30 - 09:30
Session 74: Poster discussion session
08:30 - 09:30: Session 74: Poster discussion session:
09:30 - 10:00
Coffee break
09:30 - 10:00: Coffee break:
10:00 - 11:30
Session 75: Futuristic lab: automation and AI
10:00 - 11:30: Session 75: Futuristic lab: automation and AI:
Chairperson to be announced
Xavier Pollet-Villard, France
10:00 - 10:15
Automating day 0 in the IVF laboratory: clinical validation of a three-stage workflow resulting in first pregnancies
Alejandro Chavez Badiola, Mexico
10:15 - 10:30
An image-based Artificial Intelligence (AI) model trained to predict blastocyst development from oocyte images correlates with key embryonic developmental parameters in a large dataset
10:30 - 10:45
AI-driven oocyte evaluation for indicating embryo development, quality, and aneuploidy
10:45 - 11:00
An artificial intelligence-powered tool to score fresh donor oocytes and predict blastulation: a prospective investigation at 3 Spanish IVF clinics.
Maria Cristina Urda Muñoz, Spain
11:00 - 11:15
Automated oocyte vitrification with the DaVitri device: a prospective study on survival and blastulation
11:15 - 11:30
Artificial intelligence scoring of vitrified blastocysts predicts post-warming contractions and implantation outcomes
10:00 - 11:30
Session 76: Optimizing the follicular phase
10:00 - 11:30: Session 76: Optimizing the follicular phase:
Chairperson to be announced
Chairperson to be announced
10:00 - 10:15
ADAPT-1: A multicentre, randomised, assessor-blind comparison of ovarian stimulation with follitropin delta versus follitropin alfa for in vitro fertilisation using conventional dosing regimens
10:15 - 10:30
Comparing the euploidy rate between the progestin-primed and gonadotrophin-releasing hormone antagonist protocols in preimplantation genetic testing for aneuploidy: a randomized controlled trial
10:30 - 10:45
Progestogens versus GnRH analogue protocols for prevention of LH surge in women undergoing ART: A systematic review and meta-analysis.
Evangelia Katsika, Greece
10:45 - 11:00
Follicle size at the time of trigger and oocyte maturation: does one size fit for all ovarian stimulation protocols?
Laura Marqueta, United Arab Emirates
11:00 - 11:15
Comparison of different trigger strategies on oocyte maturation rates based on ovarian response: a propensity score-matched study
11:15 - 11:30
Pregnancy and live birth rates in first blastocyst transfer: Fresh versus frozen -An individual patient data meta-analysis based on randomised controlled trials with follitropin delta
10:00 - 11:30
Session 77: Breaking boundaries in endometriosis: from the microbiome to maternal outcomes
10:00 - 11:30: Session 77: Breaking boundaries in endometriosis: from the microbiome to maternal outcomes:
Chairperson to be announced
Chairperson to be announced
10:00 - 10:15
Association between history of laparoscopically-confirmed endometriosis and cognitive function at middle-age
10:15 - 10:30
Surgery versus IVF for the treatment of infertility associated to ovarian and deep endometriosis (SVIDOE). Preliminary results from a multicenter randomized controlled trial.
10:30 - 10:45
Infertility and endometriosis: a 30-yearlong national population-based study of prevalence, association and pregnancy outcomes
Lucky Saraswat, United Kingdom
10:45 - 11:00
Treatment of endometriosis-associated pain with merigolix, an oral GnRH receptor antagonist: results from a phase 2a, randomized, double-blind, placebo-controlled study
Krzysztof Szymanowski, Poland
11:00 - 11:15
Unravelling the endometrial microbiome: relationship between pathogen prevalence and the presence of Lactobacillus species
Jose Antonio Castellón García, Spain
11:15 - 11:30
Obstetric outcome after endometriosis surgery with parametrial involvement and uterine artery section or occlusion: a prospective observational study.
Anna Katarzyna Stepniewska, Italy
10:00 - 11:30
Session 78: Innovative protocols: PPOS and random start ovarian stimulation
10:00 - 11:30: Session 78: Innovative protocols: PPOS and random start ovarian stimulation:
10:00 - 10:15
Comparing IVF outcomes of Progestin Primed Ovarian Stimulation(ppos) with ultrashort flare GNRH agonist(USF) in expected poor responders (POSEIDON 3,4) –a multicentric randomised controlled trial
poojitha chalamalasetty, India
10:15 - 10:30
Comparison of in vitro fertilization outcomes between progestin-primed and antagonist ovarian stimulation protocols
Than Trong Thach, Vietnam
10:30 - 10:45
Oral micronized progesterone (MP) vs GnRH-antagonists for LH surge prevention during controlled ovarian stimulation in oocyte donation: a randomized controlled trial.
Maria Martínez Moya, Spain
10:45 - 11:00
Luteal phase stimulation for IVF/ICSI has no effect on the yield of euploid embryos in PGT-A cycles when compared to follicular phase stimulation.
Sara Peralta, United Arab Emirates
11:00 - 11:15
Progestin-primed ovarian stimulation: Comparing the LH suppression efficacy of oral micronized progesterone and dydrogesterone
11:15 - 11:30
Oral gonadotropin-releasing hormone (GnRH) antagonist SHR7280 versus ganirelix injection in controlled ovarian hyperstimulation (COH) for assisted reproductive technologies (ART): a non-inferiority phase 3 trial
10:00 - 11:30
Session 79: Evolving fertility preservation: novel strategies and safety insights
10:00 - 11:30: Session 79: Evolving fertility preservation: novel strategies and safety insights:
Claudia Massarotti, Italy
Blandine Courbière, France
10:00 - 10:15
Impact of fertility preservation protocols on breast cancer gene expression: preliminary results
10:15 - 10:30
Optimizing oocyte in vitro maturation outcomes with gonadotropin priming in premenarcheal girls undergoing ovarian tissue cryopreservation
10:30 - 10:45
Concomitant administration of temsirolimus and anti-Müllerian hormone is effective in protecting fertility from chemotherapy-induced damage
10:45 - 11:00
Dynamic culture of human ovarian cortical tissue in perfusion bioreactor preserves the viability of stromal cells and promotes the remodeling of extracellular matrix
11:00 - 11:15
Multi-omics pleiotropic association analyses reveal prioritized genes and druggable pathways for ovarian aging
11:15 - 11:30
Cyclin-Dependent Kinase (CDK) Inhibitors are not detrimental to dormant follicles and steroidogenic function in human ovary.
Hesam Ghafouri Kalajahi, Turkey
10:00 - 11:30
Session 80: Preimplantation genetic testing: current trends and future directions
10:00 - 11:30: Session 80: Preimplantation genetic testing: current trends and future directions:
Laura Francesca Rienzi, Italy
Chairperson to be announced
10:00 - 10:15
Decoding the clinical fate of segmental mosaic embryos: key predictors of implantation and pregnancy success
Francesca Spinella, Italy
10:15 - 10:30
PGT-A provider strategies influence embryo selection and live birth rates: a multicenter analysis of 40,308 blastocyst biopsy results and 8,491 euploid embryo transfers
10:30 - 10:45
PGT-A decreases the time to pregnancy whilst not negatively impacting per cycle outcomes: A multicentre retrospective cohort study with propensity score matching
Ana Raquel Neves, Portugal
10:45 - 11:00
Optimized PGT-M strategy using gametes or arrested embryos from parents with no proband: addressing challenging cases
11:00 - 11:15
Influence of single nucleotide polymorphisms (SNPs) analysis for ploidy determination on the interpretation of pre-implantation genetic testing for aneuploidy (PGT-A) results
Carmen Rubio LLuesa, Spain
11:15 - 11:30
Clinical application of Whole-Exome Sequencing (WES)-based Preimplantation Genetic Testing (PGT) for the assessment of embryo genetics and viability
Francesco Fiorentino, Italy
10:00 - 11:30
Session 81: Poster discussion session
10:00 - 11:30: Session 81: Poster discussion session:
11:45 - 12:45
Session 82: Telling and talking to donor conceived children and adults about their donor conceived origins
11:45 - 12:45: Session 82: Telling and talking to donor conceived children and adults about their donor conceived origins:
Chairperson to be announced
11:45 - 12:05
Telling and talking about donor conception within the families: How can professionals help?
12:15 - 12:35
The experience of donor conceived people accessing donor identity
Patricia Lambert, United Kingdom
11:45 - 12:45
Session 83: Time to rethink fertility preservation in breast cancer patients
11:45 - 12:45: Session 83: Time to rethink fertility preservation in breast cancer patients:
Chairperson to be announced
11:45 - 12:05
Do all patients need fertility preservation?
12:15 - 12:35
Do we need anti-estrogen therapy in the stimulation protocols?
Christine Decanter, France
11:45 - 12:45
Session 84: Do we need new KPIs in the lab?
11:45 - 12:45: Session 84: Do we need new KPIs in the lab?:
Chairperson to be announced
11:45 - 12:05
Laboratory KPIs: Rethinking Metrics and timings
12:15 - 12:35
Cryopreservation KPIs: A Frozen Perspective
Laura Francesca Rienzi, Italy
11:45 - 12:45
Session 85: Progesterone – ways of administration
11:45 - 12:45: Session 85: Progesterone – ways of administration:
11:45 - 12:05
Go oral without limits?
11:45 - 12:45
Session 86: Poster discussion session
11:45 - 12:45: Session 86: Poster discussion session:
13:00 - 14:00
Lunch break
13:00 - 14:00: Lunch break:
14:00 - 15:15
Session 87: Considerations for the social impact of practices in IVF
14:00 - 15:15: Session 87: Considerations for the social impact of practices in IVF:
Chairperson to be announced
Chairperson to be announced
14:00 - 14:15
Unveiling the hidden danger: detection and characterisation of microplastics in human follicular and seminal fluids
Emilio Gomez - Sanchez, Spain
14:15 - 14:30
IVF and ICSI show equivalent euploidy rates in non-male factor cases: a comprehensive sibling oocyte analysis
Samyra Siqueira, United Arab Emirates
14:30 - 14:45
How many blastocysts are needed to ensure at least one euploid? The impact of maternal age and blastocyst quality on euploidy probability
Patricia Ruiz Porras, Spain
14:45 - 15:00
Does prolonged cryopreservation of blastocysts affect the implantation- and live birth rate? A Danish nationwide register-based study.
Tilde Veng Eskildsen, Denmark
15:00 - 15:15
Time to re-consider which patients benefit from a Freeze All Embryo approach: A matched analysis of over 9,700 transfers from a single centre.
Jemma Garratt, United Kingdom
14:00 - 15:15
Session 88: ART and ovarian stimulation - back to the future
14:00 - 15:15: Session 88: ART and ovarian stimulation - back to the future:
Chairperson to be announced
Anne Guivarc'h Leveque, France
14:00 - 14:15
Reproductive hormones at 7-10 years of age in children born after assisted reproductive technology
Maria Linander Vestager, Denmark
14:15 - 14:30
Regional variability in ovarian stimulation necessitates region-specific machine learning models for optimizing oocyte yield
14:30 - 14:45
Inter-cycle intra-patient variability in the retrieved oocyte numbers and ovarian response categories between consecutive IVF cycles with identical gonadotropin type, dose, and ovarian stimulation protocol
14:45 - 15:00
IGX12, an FSH-potentiating innovative therapeutic antibody for use in male and female infertility, showed good tolerability in a first-in-human, single ascending dose study
15:00 - 15:15
FIIX study: A multicentre, non-inferiority, randomised controlled trial comparing in vitro fertilisation (IVF) to intrauterine insemination with ovarian stimulation (IUI-OS) in couples with unexplained infertility
Lucy Prentice, New Zealand
14:00 - 15:15
Session 89: Molecular biology and its application in clinical IVF
14:00 - 15:15: Session 89: Molecular biology and its application in clinical IVF:
Chairperson to be announced
Chairperson to be announced
14:00 - 14:15
Human embryo implantation in vitro model using cell-engineered receptive endometrium co-cultured with euploid and aneuploid embryos unveil differences in implantation dynamics based on chromosomal status
Immaculada Sanchez Ribas, Spain
14:15 - 14:30
New facets of zona pellucida (ZP) proteins: called oocyte-specific, yet produced by the preimplantation embryo and needed for blastocyst formation
14:30 - 14:45
Association of the composite inflammation biomarker GlycA in follicular fluid with reproductive outcomes in modified natural cycle IVF
Naomi Hofsink, The Netherlands
14:45 - 15:00
First demonstration of OWLO’s new label-free 3D imaging prototype on 20 human embryos shows the potential of this technology for assessment of human blastocysts
15:00 - 15:15
Spindle transfer rescues impaired fertilization linked to Patl2-mediated dysregulation of maternal mRNA translation
Arantxa Cardona Barberán, Belgium
14:00 - 15:15
Session 90: The many facets of sperm quality and function
14:00 - 15:15: Session 90: The many facets of sperm quality and function:
Chairperson to be announced
Christine Rondanino, France
14:00 - 14:15
Analysis of human sperm behavior and assessment of non-hormonal contraceptive efficacy in a human cervix chip
14:15 - 14:30
Paternal exposure to nicotine and abstinence: post-fertilization effects of the spermatozoa and their epigenetic impact on offspring; what have we learned from the animal models?
Panagiota Tsounapi, Japan
14:30 - 14:45
Seasonal trends in sperm quality across Denmark and Florida: a study of 15,125 semen samples
14:45 - 15:00
A dopaminergic system in human sperm: novel insights into the functionality of the dopamine transporter (DAT) protein
Lisa Marie Ferguson, South Africa
15:00 - 15:15
Ooplasm-mediated sperm nuclear decondensation for genome editing of the mammalian male gamete
Angela Bryanne De Jesus, U.S.A.
14:00 - 15:15
Session 91: Changes in the endometrium: physiology and microbial impact
14:00 - 15:15: Session 91: Changes in the endometrium: physiology and microbial impact:
Chairperson to be announced
Chairperson to be announced
14:00 - 14:15
Characterization of the transcriptional changes of human endometrium across the window of implantation during natural cycles reveals consistent dynamics
Irene Miguel-Escalada, Spain
14:15 - 14:30
Can a healthy gut modulate the cervicovaginal immune response to an adverse vaginal microbiota?
Karen Grewal, United Kingdom
14:30 - 14:45
Impact of personalized nutrition and Lactobacillus crispatus-M247 administration on euploid blastocyst transfer outcomes in patients with unhealthy lifestyles: A matched case-control study.
14:45 - 15:00
Detection of microbial pathogens in endometrium alters the endometrial immune status and significantly lowers success rates in assisted reproduction treatments
15:00 - 15:15
The effects of placental invasion on the maternal cells in the decidua of early pregnancy
14:00 - 15:15
Session 92: Tracking health from ART pregnancies to childhood
14:00 - 15:15: Session 92: Tracking health from ART pregnancies to childhood:
Chairperson to be announced
Chairperson to be announced
14:00 - 14:15
Predictive performance of the Fetal-Medicine-Foundation first-trimester screening for preeclampsia in pregnancies following ART with fresh embryo transfer, frozen embryo transfer and oocyte donation
Anna Sophie Lebech Kjaer, Denmark
14:15 - 14:30
What are the clinical implications of large-for-gestational age (LGA) babies conceived after a frozen-thawed embryo transfer (FET)?: a population-based cohort study
14:30 - 14:45
The risk of birth defects identified during the first year of life is not associated with embryo stage at transfer among IVF-conceived children
Katherine Cameron, U.S.A.
14:45 - 15:00
Characterizing the association between in vitro fertilization and VACTERL: a population-based assessment in 1.3 million live births
15:00 - 15:15
Cancer occurrence in women after medically assisted reproduction: a population-based cohort study
15:30 - 16:30
Closing reception
15:30 - 16:30: Closing reception: